Back
HCI Group, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
50
HCI
HCI Group, Inc.
Last Price:
$196.16
Seasonality Move:
9.79%
Buy
64
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
50
HCI Group, Inc. (HCI)
is a Sell
Is HCI Group, Inc. a Buy, Sell or Hold?
-
The current HCI Group, Inc. [HCI] share price is $193.90. The Score for HCI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
HCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HCI Stock Price Chart
What is HCI Group, Inc.'s stock price today?
-
The HCI Group, Inc. share price today is $193.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.
HCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.82 | Buy |
| Relative Strength Index (14 RSI): | 64.13 | Buy |
| Chaikin Money Flow: | 112808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (171.78 - 185.34) | Buy |
| Bollinger Bands (100): | (162.71 - 195.57) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.08 | Buy |
| Relative Strength Index (14 RSI): | 79.16 | Buy |
| Chaikin Money Flow: | -97373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 32.35) | Buy |
| Bollinger Bands (100): | (10.77 - 23.75) | Buy |
HCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 187.52 | Buy |
| 20-day SMA: | 179.93 | Buy |
| 50-day SMA: | 187.38 | Buy |
| 200-day SMA: | 163.98 | Buy |
| 8-day EMA: | 187.15 | Buy |
| 20-day EMA: | 183.41 | Buy |
| 50-day EMA: | 182.9 | Buy |
| 200-day EMA: | 164.19 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.51 | Buy |
| 20-day SMA: | 28.33 | Buy |
| 50-day SMA: | 21.67 | Buy |
| 200-day SMA: | 13.52 | Buy |
| 8-day EMA: | 33.02 | Buy |
| 20-day EMA: | 28.99 | Buy |
| 50-day EMA: | 23.45 | Buy |
| 200-day EMA: | 17.42 | Buy |
HCI Group, Inc. Earnings Growth & HCI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.08 per share, and a decrease next year of $3.74 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
HCI Group, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||